Kunming Qi

机构：Jiangsu Normal University, Xuzhou Medical College, Affiliated Hospital of Xuzhou Medical College · ORCID：0000-0002-0717-9133

发表论文 123 篇 · 总被引 1708 次 · h-index 21

代表论文

• Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial (2024 · Nature Communications · 被引 112)
• Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial (2024 · The Lancet Haematology · 被引 56)
• Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial (2025 · The Lancet Haematology · 被引 22)
• Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐ BCMA CAR T‐cell‐based therapy (2024 · American Journal of Hematology · 被引 22)
• Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma (2025 · Blood · 被引 20)
• A Review of Research Progress on Cables and Towed Objects of the Ocean Engineering Towing System (2025 · Journal of Marine Science and Engineering · 被引 16)